An interventional study of Core Strengthening with Diaphragmatic Breathing and core strengthening with pilate breathing in Diabetes Type II, sponsored by Foundation University Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 30 Years to 55 Years. Per ClinicalTrials.gov, last updated 2025-12-18.
Sponsored by Foundation University Islamabad · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 98 studies in Diabetes Mellitus, Type 2 with a site in Pakistan — 28 open to participants now, 35 under way, 2 of them phase 3. Diabetes Mellitus, Type 2 · Pakistan.
Among the 98 studies in Diabetes Mellitus, Type 2 with a site in Pakistan, this one is the 63rd largest by planned enrollment of the 89 interventional ones that give a count, is one of 16 that started in 2025, is one of 59 with no phase, reaches primary completion later than 13 of the 34 other live ones, and was the 73rd registered.
10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.
Browse Diabetes Mellitus, Type 2 studies →28 of the 98 studies in Diabetes Mellitus, Type 2 with a site in Pakistan are open now. Recruiting first, the newest first:
Riphah International University · Sites in Pakistan
Ages 40–65
Green International University · Sites in Pakistan
Ages 30–65
Ibadat International University, Islamabad · Sites in Pakistan
Ages 50–70
Khyber Medical University Peshawar · Sites in Pakistan
Ages 20+ · Healthy volunteers
Riphah International University · Sites in Pakistan
Ages 40–80
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.
This study: 30 Years to 55 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
98 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 5 · Phase 3 3 · Phase 4 21
First in 2006; this study’s year is marked. 16 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 56 is below the median of 80 across 8,372 interventional studies indexed under Diabetes Mellitus, Type 2.
Median enrollment 99 across the 89 interventional studies, 1,031 across the 9 observational. Of the 56 that completed or were terminated, 5 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
15 of 98 have an industry lead sponsor. The 10 most frequent:
Foundation University Islamabad is the lead sponsor of 255 studies on the registry; 142 are open to participants now.
Foundation University Islamabad has 2 studies filed under Diabetes Mellitus, Type 2 — fewer than ten, so there is no comparison to draw.
12 of the studies in Diabetes Mellitus, Type 2 with a site in Pakistan that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07073768Phase 3Khyber Medical College, PeshawarComparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients | 2026-12-26 |
| NCT06570057Baqai Institute of Diabetology and EndocrinologyFeasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors | 2026-11 |
| NCT06561126Khyber Medical University PeshawarEngagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D] | 2026-11-30 |
| NCT07814742National University of Medical Sciences, PakistanEffectiveness of UrDiaCare | 2026-12-31 |
| NCT05164263Getz PharmaReal World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study | 2026-12-31 |
Add all 12 to your calendar (.ics) → With an account.
Among the 98 studies in Diabetes Mellitus, Type 2 with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Diabetes type II is a metabolic syndrome involving high sugar levels known as hyperglycemia. It can impair pulmonary function through reduced lung elasticity and gas exchange and weaken core muscles due to inflammation and muscle atrophy. Literature has shown the individual effects of these exercises on quality of life. However, no study has yet evaluated the combined effects of these exercises on different variables such as lung function, functional capacity, and blood sugar levels.
OBJECTIVE: The objective of this study is to compare the effects of diaphragmatic breathing and Pilates breathing, combined with core strengthening exercises, on lung function, functional capacity, blood sugar levels, and quality of life. The study aims to determine which breathing technique provides greater physiological and functional benefits.
METHOD: The study will be a Randomized control trial consisting of two groups subjects meeting the inclusion criteria will be selected for the study. The subjects will then be randomly assigned to two groups. One group will receive Diaphragmatic breathing with core strengthening exercises and other group will receive Pilate breathing with core strengthening exercises. Before initiating the treatment procedure following would be assessed for all the patients: Pulmonary Function, Functional Capacity, Blood sugar levels and quality of life. Afterwards a treatment regime distributed over the course of six weeks will be given to all patients. After the interventions Pulmonary function, Functional capacity, Blood sugar levels and Quality of life would be reassessed. Data would be analyzed to evaluate the outcomes.
DATA COLLECTION PROCEDURE: The participants eligible for the study according to inclusion and exclusion criteria would be recruited for the study voluntarily and referred from Medical OPD of Fauji Foundation Hospital and Rehab OPD of Fauji Foundation Hospital. The purpose of this study along with the treatment plan would be explained to the participants in the language they understand their best and informed consent will be taken from the participants. A treatment regimen consisting of 18 weeks distributed over the course of six weeks will be provided to the patients in multidisciplinary lab of foundation University College of physical therapy
Diabetes type II is an expanding global problem linked to several factors such as obesity, unhealthy diet, and physical inactivity. The two most common causes are impaired insulin secretion or insulin resistance. Diabetes type II is a major health burden for the elderly population, affecting approximately 25% of individuals over the age of 65 years. Recently, increased attention has been paid to the loss of muscle power and sarcopenia in individuals with type II diabetes, as these conditions compromise both physical and psychological health, significantly affecting overall quality of life. Diabetes type II is a heterogeneous disorder affecting multiple organs. The alveolar capillary network, a large microvascular unit in the lungs, may be associated with the condition. Functional capacity is a strong predictor of survival in many diseases, including diabetes type II. Patients are more likely to experience functional impairments due to poor glycemic control and associated complications. Symptoms such as inadequate metabolic control, episodes of hypoglycemia, fear of hypoglycemia, and changes in lifestyle collectively lead to poor health-related quality of life, with reductions in functional performance. Activities of daily living and overall quality of life are often most affected by vascular complications in diabetes type II. Reduced lung function and impaired gas transfer are also linked to the disease. Chronic hyperglycemia causes the production of reactive oxygen species due to a process known as non-protein enzymatic glycation. Advanced glycation and continuous oxidative stress trigger a chronic inflammatory response. Additionally, there is a considerable decrease in glucose uptake in the skeletal muscles of patients with diabetes type II. Due to impaired insulin production and utilization, patients experience a constant state of elevated blood sugar levels that can lead to severe short-term and long-term consequences. Diabetes type II, therefore, represents a complex disorder characterized by defects in insulin production and utilization. Research also indicates that diets containing high sugar content, refined foods, and high-calorie foods significantly increase the risk of developing diabetes type II.
This study aims to explore the combined effects of treatment regimens on pulmonary function, functional capacity, random blood sugar levels, and quality of life. The investigation seeks to provide a deeper understanding of the effects of these interventions on various health variables.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
detailed components of core strengthening exercises and diaphragmatic breathing
Other: Core Strengthening with Diaphragmatic Breathing
detailed components of core strengthening exercises and pilate breathing
Other: core strengthening with pilate breathing
Swiss Ball Seated Marching: Sit on the ball with feet flat on the floor, hip-width apart. Keep the back straight and core engaged. Slowly lift right foot a few inches off the ground. Hold for 1-2 seconds, then lower. Lift left foot the same way. Continue alternating in a slow, controlled motion.
Pilates Breathing Sit/lie in neutral spine, hand on ribs \& stomach. Inhale through nose, expand ribs (not shoulders). Exhale, draw navel to spine, engage core. Core Strengthening Abdominal Bracing: Tighten abs, hold while breathing. Pelvic Tilt: Flatten lower back, lift tailbone slightly. Hold 5-10s. Dead Bug: Lower opposite arm \& leg, return. Alternate. Quadruped (Bird Dog): On all fours, extend opposite arm \& leg. Hold 2-3s. Plank: Forearms down, straight body. Hold 20-60s. Bridge: Lift hips, squeeze glutes, lower slowly. Segmental Rolling: Roll with upper body first, then lower body. Swiss Ball Marching: Sit tall, lift one foot at a time.
pulmonary Function
Pulmonary function will be assessed using spirometry following standard ATS/ERS procedures. Key parameters recorded will include FVC, FEV₁, and the FEV₁/FVC ratio. Spirometry will be used to evaluate baseline respiratory status and monitor any changes over time.
Time frame: 6 weeks
Functional capacity
Functional capacity will be assessed using the 6-Minute Walk Test (6MWT). Participants will be instructed to walk at their usual pace for six minutes along a standardized, measured corridor. The total distance walked (in meters) will be recorded as the outcome. Standardized encouragement and safety monitoring will be followed according to established guidelines.
Time frame: 6 weeks
Blood sugar levels
Blood sugar level will be measured using a calibrated glucometer. A capillary blood sample will be obtained via finger-prick, and glucose concentration will be recorded in mg/dL according to standard operating procedures.
Time frame: 6 weeks
Started Aug 2025 (actual). Primary completion is estimated for Jan 2026, 4 months after the start.
Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 4 months is below that.
Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Foundation University Islamabad →